These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 2411797)
21. Systemic alkalinization inhibits the ability of flavone acetic acid to augment natural killer activity, induce cytokine gene expression, and synergize with interleukin 2 for the treatment of murine renal cancer. Futami H; Hornung RL; Back TT; Bull R; Gruys E; Wiltrout RH Cancer Res; 1990 Dec; 50(24):7926-31. PubMed ID: 2253233 [TBL] [Abstract][Full Text] [Related]
22. The effects of in vitro hyperthermia on natural killer activity from lung, blood and spleen. Yang H; Mitchel R; Lemaire I J Clin Lab Immunol; 1990 Jul; 32(3):117-22. PubMed ID: 1726330 [TBL] [Abstract][Full Text] [Related]
23. Selective impairment of alpha-interferon-mediated natural killer augmentation in Sjögren's syndrome: differential effects of alpha-interferon, gamma-interferon, and interleukin 2 on cytolytic activity. Takeda A; Minato N; Kano S Clin Exp Immunol; 1987 Nov; 70(2):354-63. PubMed ID: 2448073 [TBL] [Abstract][Full Text] [Related]
24. Cytokines involved in the augmentation of murine natural killer cell activity by pyrimidinones in vivo. Richard KA; Mortensen RF; Tracey DE J Biol Response Mod; 1987 Dec; 6(6):647-63. PubMed ID: 2453616 [TBL] [Abstract][Full Text] [Related]
25. Regulation of natural killer cytotoxicity by recombinant alpha interferons. Augmentation by IFN-alpha 7, an interferon similar to IFN-alpha J. Platsoucas CD; Fox FE; Oleszak E; Fong K; Nanno M; Ioannides CG; Trotta PP Anticancer Res; 1989; 9(4):849-58. PubMed ID: 2817813 [TBL] [Abstract][Full Text] [Related]
26. Regulation of natural killer cytotoxicity by Escherichia coli-derived human interferon gamma. Platsoucas CD Scand J Immunol; 1986 Jul; 24(1):93-108. PubMed ID: 3088722 [TBL] [Abstract][Full Text] [Related]
27. Changes in number and density of large granular lymphocytes upon in vivo augmentation of mouse natural killer activity. Santoni A; Piccoli M; Ortaldo JR; Mason L; Wiltrout RH; Herberman RB J Immunol; 1985 Apr; 134(4):2799-810. PubMed ID: 2579157 [TBL] [Abstract][Full Text] [Related]
28. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice. Brunda MJ; Taramelli D; Holden HT; Varesio L J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831 [TBL] [Abstract][Full Text] [Related]
29. Modulation of murine natural killer cell activity in vitro and in vivo by recombinant human interferons. Brunda MJ; Rosenbaum D Cancer Res; 1984 Feb; 44(2):597-601. PubMed ID: 6692364 [TBL] [Abstract][Full Text] [Related]
30. Activation of mouse macrophages by pyran copolymer and role in augmentation of natural killer activity. Puccetti P; Santoni A; Riccardi C; Holden HT; Herberman RB Int J Cancer; 1979 Dec; 24(6):819-25. PubMed ID: 232496 [TBL] [Abstract][Full Text] [Related]
31. Activation of natural killer cells in newborn piglets by interferon induction. Lesnick CE; Derbyshire JB Vet Immunol Immunopathol; 1988 Mar; 18(2):109-17. PubMed ID: 2838948 [TBL] [Abstract][Full Text] [Related]
32. Strain difference in mouse natural killer activity augmented by mouse interferon and poly I.C. Kiuchi Y Jikken Dobutsu; 1986 Jul; 35(3):239-44. PubMed ID: 2429851 [TBL] [Abstract][Full Text] [Related]
33. Interleukin-2 (IL-2) activated natural killer (A-NK) cells: binding to microvascular endothelial cells and BRM enhancement of cytolytic activity. Brunson KW; Ohashi M; Miller CA; Kitson RP; Basse PH; Goldfarb RH In Vivo; 1994; 8(1):71-5. PubMed ID: 8054514 [TBL] [Abstract][Full Text] [Related]
34. Murine lymph node natural killer cells: regulatory mechanisms of activation or suppression. Hisano G; Hanna N J Natl Cancer Inst; 1982 Sep; 69(3):665-71. PubMed ID: 6180211 [TBL] [Abstract][Full Text] [Related]
35. Immunomodulatory effects in mice of polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose. Talmadge JE; Adams J; Phillips H; Collins M; Lenz B; Schneider M; Schlick E; Ruffmann R; Wiltrout RH; Chirigos MA Cancer Res; 1985 Mar; 45(3):1058-65. PubMed ID: 3155990 [TBL] [Abstract][Full Text] [Related]
36. In vitro potentiation of human natural killer cell activity by a streptococcal preparation, OK-432: interferon and interleukin-2 participation in the stimulation with OK-432. Wakasugi H; Kasahara T; Minato N; Hamuro J; Miyata M; Morioka Y J Natl Cancer Inst; 1982 Oct; 69(4):807-12. PubMed ID: 6181282 [TBL] [Abstract][Full Text] [Related]
37. Conditioned augmentation of natural killer cell activity. Independence from nociceptive effects and dependence on interferon-beta. Solvason HB; Ghanta VK; Hiramoto RN J Immunol; 1988 Jan; 140(2):661-5. PubMed ID: 2826599 [TBL] [Abstract][Full Text] [Related]
38. Trafficking and activation of murine natural killer cells: differing roles for IFN-gamma and IL-2. Sayers TJ; Mason LH; Wiltrout TA Cell Immunol; 1990 May; 127(2):311-26. PubMed ID: 2109662 [TBL] [Abstract][Full Text] [Related]
39. Role of macrophage in in vitro augmentation of rat, mouse, and human natural killer activities. Reynolds CW; Brunda MJ; Holden HT; Herberman RB J Natl Cancer Inst; 1981 May; 66(5):837-42. PubMed ID: 6164813 [TBL] [Abstract][Full Text] [Related]
40. Natural killer cell activity in the rat. VI. Characterization of rat large granular lymphocytes as effector cells in natural killer and antibody-dependent cellular cytotoxic activities. Fukui H; Overton WR; Herberman RB; Reynolds CW J Leukoc Biol; 1987 Feb; 41(2):130-42. PubMed ID: 2433376 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]